invitro
metabolit
drug
detect
reli
design
materialsbas
analyt
platform
univers
use
biomed
research
clinic
practic
howev
metabol
analysi
biosampl
need
tediou
sampl
prepar
due
sampl
complex
low
molecular
abund
challeng
construct
diagnost
tool
herein
develop
platform
use
silver
nanoshel
synthes
sio
ag
tunabl
shell
structur
multicycl
silver
mirror
reaction
optim
nanoshel
achiev
direct
laser
desorptionion
mass
spectrometri
biofluid
appli
nanoshel
diseas
diagnosi
therapeut
evalu
identifi
patient
postop
brain
infect
daili
monitor
glucos
quantit
cerebrospin
fluid
measur
drug
distribut
blood
cerebrospin
fluid
system
valid
function
bloodbraincerebrospin
fluidbarri
pharmacokinet
work
shed
light
design
materi
advanc
metabol
analysi
precis
diagnost
nvitro
metabol
diagnosi
reli
design
materialsbas
analyt
platform
detect
select
metabolit
biolog
sampl
key
role
diseas
detect
therapeut
evalu
clinic
current
inorgan
organ
materi
use
metabol
analysi
select
spectroscopi
method
includ
nuclear
magnet
reson
spectroscopi
biochem
analyz
mass
spectrometri
ms
et
al
contrast
method
ms
enjoy
uniqu
advantag
high
accuraci
sensit
resolut
throughput
howev
efficaci
ms
spectroscopi
method
determin
rigor
sampl
pretreat
procedur
enrich
purif
due
high
sampl
complex
low
molecular
abund
biolog
sampl
date
msbase
analysi
metabolit
biofluid
still
unsatisfactori
term
select
speed
cost
reproduc
clinic
use
therefor
address
challeng
sampl
pretreat
design
materi
platform
urgent
demand
advanc
invitro
metabol
diagnosi
matrixassist
laser
desorptionion
maldi
ms
display
great
superior
consid
fast
analysi
analyt
second
accur
mass
measur
identif
simpl
sampl
prepar
broad
applic
high
sensit
low
cost
practic
use
inorgan
particl
eg
silicon
carbon
metal
metal
oxid
prefer
matric
ldi
ms
small
metabolit
report
research
group
global
includ
particl
control
analyt
variat
background
signal
mass
region
mz
achiev
qualit
analysi
small
metabolit
carbohydr
amino
acid
coupl
ldi
ms
isotop
quantif
design
particl
enabl
metabol
analysi
rare
cell
eg
circul
tumor
cell
notabl
ldi
perform
particl
far
ideal
select
detect
small
metabolit
deal
complex
biofluid
real
case
result
applic
particleassist
ldi
ms
clinic
diagnost
challeng
need
ration
design
materi
use
plasmon
particl
consist
nobl
metal
includ
limit
au
ag
pt
pd
provid
uniqu
surfac
plasmon
reson
hot
carrier
laser
irradi
ideal
matrix
use
despit
mani
report
applic
plasmon
particl
ldi
ms
current
work
focus
use
solid
plasmon
particl
divers
shape
report
plasmon
nanoshel
plasmon
au
nanoshel
nanosc
surfac
rough
higher
hot
carrier
product
solid
au
particl
demonstr
better
candid
ldi
ms
detect
small
metabolit
wherea
schemat
workflow
materi
character
schemat
diagram
experiment
workflow
b
ldi
ms
process
use
sio
ag
nanoshel
matrix
electron
micrograph
imag
c
sio
sio
e
sio
f
sio
includ
tem
imag
particl
hrtem
show
silver
crystal
lattic
inset
c
sem
imag
particl
g
averag
size
distribut
sio
sio
ag
particl
water
dl
h
elementari
composit
analysi
sio
sio
ag
particl
uvvi
absorpt
spectra
sio
sio
ag
particl
scale
bar
nm
tem
nm
sem
applic
limit
complex
biofluid
diagnost
purpos
notabl
analyt
perform
plasmon
nanoshel
depend
select
nobl
metal
adsorb
ultraviolet
uv
laser
optim
shell
structur
ldi
ms
detect
design
plasmon
nanoshel
would
achiev
effici
ldi
ms
metabol
analysi
real
case
clinic
applic
develop
far
work
report
platform
base
design
plasmon
silver
nanoshel
direct
detect
small
metabolit
clinic
invitro
metabol
diagnost
first
synthes
seri
sio
ag
coreshel
particl
tunabl
nanoshel
structur
multicycl
silver
mirror
reaction
surfac
sio
nanoparticl
optim
plasmon
silver
nanoshel
new
matric
allow
fast
multiplex
sensit
select
ldi
ms
detect
small
metabolit
biofluid
without
enrich
purif
furthermor
coupl
isotop
quantif
select
metabolit
demonstr
use
silver
nanoshel
diseas
detect
therapeut
evalu
clinic
diseas
detect
identifi
patient
postop
brain
infect
glucos
quantit
daili
monitor
cerebrospin
fluid
csf
analysi
therapeut
evalu
investig
drug
distribut
blood
csf
system
valid
function
permeabl
bloodbraincsfbarri
therapeut
treatment
patient
cerebr
edema
pharmacokinet
studi
work
shed
light
design
materi
highperform
metabol
analysi
precis
diagnost
real
case
prepar
character
silver
nanoshel
synthes
silver
nanoshel
also
denot
sio
ag
hard
templat
method
fig
shell
structur
control
use
multicycl
silver
mirror
reaction
ldi
ms
fig
reaction
temperatur
time
critic
optim
synthesi
process
supplementari
fig
see
also
method
detail
prepar
monodispers
silica
particl
method
averag
size
nm
polydispers
index
pdi
core
materi
supplementari
tabl
supplementari
fig
first
cycl
silver
mirror
reaction
anchor
silver
nanoparticl
size
nm
onto
surfac
silica
particl
sio
fig
highresolut
transmiss
electron
microscopi
hrtem
demonstr
typic
inter
planar
space
silver
composit
along
direct
inset
fig
multipl
cycl
two
cycl
sio
three
cycl
sio
four
cycl
sio
silver
mirror
reaction
observ
gradual
increas
shell
thick
silver
nanoparticl
size
sio
fig
sio
fig
sio
fig
due
seedmedi
growth
process
character
morpholog
sio
ag
show
control
nanosc
surfac
rough
nanocrevic
scan
electron
microscopi
sem
multicycl
silver
mirror
reaction
fig
electricityheat
insul
materi
silica
core
sio
ag
contribut
produc
hot
carrier
retain
heat
ldi
process
wherea
silver
shell
excit
nm
laser
moreov
shown
element
map
analysi
supplementari
fig
distribut
carbon
small
metabolit
silver
shell
afford
similar
silver
nanoparticl
densiti
surfac
fig
silver
load
ratio
weight
silicon
core
nanoshellsmetabolit
hybrid
demonstr
small
molecul
trap
nanocrevic
surfac
silver
nanoshel
would
crucial
effici
ldi
small
metabolit
also
examin
import
structur
paramet
ldi
ms
matrix
use
includ
dispers
zeta
potenti
surfac
area
composit
lightabsorb
prepar
sio
ag
dynam
light
scatter
dl
experi
sio
ag
show
fine
dispers
water
pdi
supplementari
tabl
particl
size
increas
nm
nm
fig
multicycl
silver
mirror
reaction
consist
transmiss
electron
microscopi
tem
sem
result
confirm
control
synthesi
sio
ag
obtain
similar
result
three
batch
materi
parallel
demonstr
reproduc
synthet
method
signific
differ
p
supplementari
fig
sio
ag
particl
neg
charg
zeta
potenti
mv
mv
supplementari
tabl
supplementari
fig
benefici
format
ion
layer
surfac
toward
na
k
ag
adduct
nitrogen
adsorpt
analysi
obtain
type
iv
isotherm
supplementari
fig
suggest
stack
mesopor
structur
materi
surfac
calcul
surfac
area
sio
ag
base
multipoint
brunauer
emmett
teller
bet
model
sio
ag
enjoy
larger
surfac
area
g
compar
bare
sio
particl
g
increas
surfac
rough
introduct
silver
p
supplementari
tabl
increas
averag
size
silver
nanoshel
correl
similar
increas
surfac
area
due
chang
densiti
similar
previou
report
investig
composit
materi
record
correspond
energi
dispers
xray
edx
spectra
fig
supplementari
fig
yield
increas
silver
load
ratio
weight
sio
sio
sio
sio
consist
supplementari
fig
sio
explor
light
absorb
particl
perform
ultravioletvis
uvvi
spectroscopi
analysi
fig
supplementari
fig
pure
silica
particl
uvvi
absorpt
peak
similar
refer
report
wherea
sio
particl
display
absorpt
peak
nm
due
mie
plasmon
reson
excit
silver
nanoparticl
fourth
reduct
cycl
absorpt
peak
red
shift
nm
sio
p
due
enhanc
plasmon
coupl
aggreg
excess
silver
surfac
silica
core
particl
agre
tem
sem
fig
specif
increas
maximum
absorpt
peak
observ
supplementari
fig
three
batch
silver
nanoshel
parallel
notabl
absorpt
band
silver
close
nm
wavelength
nd
yag
laser
use
ldi
ms
benefici
matrix
use
compar
gold
nanoparticl
light
absorb
increas
plasmon
reson
peak
becam
broader
higher
load
ratio
silver
agre
tem
sem
dl
edx
character
demonstr
adjust
properti
silver
nanoshel
multicycl
silver
mirror
reaction
compar
previou
literatur
mostli
focus
coreshel
particl
either
dispers
ag
nanoparticl
nm
surfac
thick
nm
dens
pack
shell
structur
surfac
coat
techniqu
work
featur
sio
ag
afford
thin
nm
discontinu
tunabl
silver
nanoshel
fig
surfac
chemistri
silver
nanoshel
adjust
consid
bind
affin
thiol
group
silver
employ
thiolaptam
modifi
silver
nanoshel
observ
new
uvvi
absorpt
peak
nm
nucleic
acid
composit
supplementari
fig
indic
success
function
aptam
valid
surfac
chemistri
modifi
materi
fourier
transform
infrar
ftir
spectroscopi
supplementari
fig
appear
typic
peak
ch
cm
cm
po
cm
cm
co
cm
confirm
function
surfac
silver
nanoshel
modif
aptam
may
allow
target
enrich
select
detect
specif
molecul
select
design
sio
ag
ldi
ms
analysi
select
optim
materi
appli
sio
ag
new
matric
analysi
small
metabolit
mix
sio
ag
particl
differ
analyt
solut
dri
mixtur
direct
ldi
ms
notabl
obtain
strong
silver
ionsadduct
molecular
peak
spectra
fig
ag
close
evidenc
even
isotop
abund
silver
natur
product
mag
ion
competit
ag
ion
cation
molecul
contain
dewar
model
polar
function
group
like
hydroxyl
group
iondipol
interact
specif
sio
afford
highest
mean
signal
intens
triplic
experi
superior
sio
supplementari
fig
sio
sio
sio
p
fig
c
supplementari
tabl
addit
view
molecular
peak
na
adduct
well
supplementari
fig
select
optim
sio
ag
ldi
ms
analysi
ng
mannitol
b
glucos
c
methionin
posit
ion
mode
use
sio
sio
sio
sio
matric
includ
typic
mass
spectra
show
silveradduct
molecular
peak
these
metabolit
mean
intens
signal
obtain
use
differ
sio
ag
particl
matric
error
bar
calcul
sd
three
measur
p
onesid
ttest
mass
spectra
nm
lysin
methionin
arginin
phenylalanin
nacl
e
nm
leucin
methionin
arginin
glucos
mg
ml
bovin
serum
albumin
solut
kcl
concentr
sio
ag
key
paramet
differ
physic
chemic
properti
variou
small
metabolit
lead
differ
ioniz
effici
observ
even
use
given
sio
ag
ldi
ms
analysi
sio
thin
pack
silver
layer
fig
afford
structur
stabil
specif
nanogap
surfac
plasmon
reson
lead
significantli
higher
perform
sio
sio
overload
silver
silica
sio
reduc
analyt
effici
sio
owe
surfac
aggreg
excess
silver
silica
core
fig
supplementari
fig
rather
clump
sio
ag
particl
fig
supplementari
fig
insuffici
load
silver
sio
sio
also
affect
analyt
effici
sio
fig
due
surfac
area
silica
core
expos
metabolit
less
specif
silver
nanocrevic
notabl
uniqu
silver
peak
ag
use
mass
calibr
spectrum
accur
analyt
identif
addit
bare
silver
nanoshel
surfac
function
molecular
probe
lead
specif
captur
molecul
demonstr
enrich
kanamycin
use
aptamersfunction
silver
nanoshel
detect
molecular
peak
mz
supplementari
fig
result
suggest
silver
nanoshel
may
serv
volatil
platform
select
sensit
captur
detect
target
molecul
studi
salt
toler
protein
endur
design
silver
nanoshel
sio
small
metabolit
detect
low
abund
fundament
import
realcas
applic
complex
biofluid
deal
mixtur
four
small
metabolit
nm
highli
concentr
nacl
solut
fig
fig
complex
sampl
contain
protein
mg
ml
bsa
salt
kcl
solut
still
observ
clear
silver
ionsadduct
signal
fig
ag
glucos
demonstr
fine
salt
toler
multiplex
sio
practic
use
nanocrevic
silver
nanoshel
trap
small
analyt
transfer
laser
energi
select
desorptionion
process
wherea
mass
spectrometri
serv
ideal
tool
screen
divers
metabolit
simultan
high
throughput
diagnosi
postop
brain
infect
csf
detect
incid
postop
central
nervou
system
infect
neurosurg
procedur
global
even
higher
antibiot
prophylaxi
appli
time
significantli
csf
detect
decis
identifi
patient
postop
brain
infect
glucos
level
csf
affirm
diagnosi
criteria
howev
present
measur
glucos
level
csf
diagnost
use
tradit
biochem
method
encount
mani
problem
includ
tediou
sampl
pretreat
long
time
biochem
reaction
larg
sampl
consumpt
forth
use
design
silver
nanoshel
within
minut
overal
experi
directli
detect
na
adduct
glucos
mz
fig
ag
adduct
glucos
mz
fig
togeth
mannitol
mz
small
metabolit
supplementari
tabl
consum
nativ
csf
besid
accur
mass
measur
also
perform
msm
analysi
signal
compar
result
tandem
mass
spectra
standard
identif
supplementari
fig
mention
ldi
ms
usual
use
qualit
semiquantit
analysi
ms
peak
intens
use
quantif
owe
nonpredict
analytedepend
ion
product
behavior
thu
coupl
isotop
quantif
measur
concentr
glucos
diagnost
purpos
csf
afford
consist
calibr
curv
coeffici
determin
r
use
isotop
six
c
fig
use
one
c
supplementari
fig
figur
show
one
typic
mass
spectrum
analyt
five
experi
supplementari
fig
show
four
isotop
analyteisotop
ai
ratio
notabl
compar
biochem
method
base
quantif
sampl
volum
reduc
experi
time
reduc
hour
sever
minut
ldi
ms
isotop
quantif
afford
averag
recoveri
coeffici
variat
cv
within
fig
compar
biochem
method
afford
averag
recoveri
cv
within
supplementari
fig
conclud
silver
nanoshel
sio
assist
ldi
ms
achiev
fast
sensit
accur
multiplex
quantit
reproduc
detect
small
metabolit
nativ
csf
without
enrich
purif
appli
silver
nanoshellsassist
ldi
ms
monitor
glucos
level
patient
csf
diagnosi
postop
brain
infect
differ
blood
system
glucos
level
csf
stabl
energi
sourc
brain
vital
role
neurotransmitt
synthesi
synapt
neurotransmiss
postop
brain
infect
caus
low
glucos
level
csf
due
metabol
oper
introduc
bacteria
threshold
glucos
level
mm
continu
drain
csf
demonstr
earlier
report
display
fig
patient
brain
infect
glucos
level
mm
consecut
day
oper
suggest
postop
brain
infect
comparison
measur
glucos
level
patient
without
infect
mm
use
silver
nanoshellsassist
ldi
ms
also
consecut
day
fig
detect
csf
sampl
infect
patient
csf
sampl
uninfect
control
approach
fig
show
consist
current
biochem
method
use
hospit
afford
coeffici
determin
r
supplementari
fig
see
also
supplementari
tabl
detail
obtain
optim
diagnost
sensit
specif
base
cutoff
valu
mm
accord
receiv
oper
characterist
roc
curv
area
curv
roc
auc
fig
previou
ldi
ms
approach
mostli
limit
standard
analysi
spike
experi
imag
test
consid
difficulti
sampl
pretreat
complex
biofluid
enrich
purif
demonstr
demonstr
clinic
diagnosi
patient
postop
brain
infect
well
daili
monitor
advanc
ldi
ms
analysi
csf
use
silver
nanoshel
design
structur
paramet
pharmacokinet
studi
serum
csf
drug
treatment
pharmacokinet
studi
guid
overal
therapeut
appli
univers
clinic
divers
medic
treatment
instrument
understand
distribut
metabol
select
drug
pharmacokinet
studi
instanc
mannitol
small
metabolit
long
employ
reduc
intracrani
pressur
increas
cerebr
perfus
blood
flow
clinic
treatment
nevertheless
monitor
concentr
small
metabolitesdrug
eg
mannitol
serum
csf
difficult
tradit
electrospray
ioniz
esi
ms
techniqu
due
high
sampl
complex
low
molecular
abund
requir
enrich
separ
chemoselect
extract
liquidga
chromatographi
timeconsum
laborintens
expens
largescal
use
nativ
serum
directli
obtain
na
adduct
mannitol
mz
fig
ag
adduct
mannitol
mz
fig
togeth
glucos
mz
small
metabolit
supplementari
tabl
base
optim
silver
nanoshel
compar
tandem
mass
spectra
signal
biosampl
standard
addit
accur
mass
measur
identif
supplementari
fig
control
experi
observ
signal
ldi
ms
without
matrix
due
low
ldi
effici
supplementari
fig
obtain
overwhelm
background
nois
peak
small
metabolit
use
organ
matrix
eg
acid
chca
supplementari
fig
recogn
glucos
signal
use
inorgan
matrix
gold
nanoparticl
supplementari
fig
demonstr
advantag
silver
nanoshel
current
matric
bioanalysi
diagnost
purpos
also
appli
isotop
quantif
measur
concentr
mannitol
serum
calibr
curv
afford
coeffici
determin
r
dynam
rang
ng
fig
high
reproduc
serum
detect
standard
deviat
five
independ
test
supplementari
fig
also
examin
stabil
silver
nanoshel
serum
detect
found
sio
ag
capabl
ldi
ms
analysi
least
month
supplementari
fig
notabl
despit
high
sampl
complex
serum
achiev
effici
ldi
ms
analysi
small
metabolit
without
sampl
pretreat
similar
csf
detect
valid
perform
silver
nanoshel
sio
complex
biofluid
monitor
concentr
chang
mannitol
serum
csf
demonstr
distribut
mannitol
blood
csf
system
therapeut
treatment
three
patient
cerebr
edema
notabl
blood
braincsf
system
divid
bloodbraincsfbarri
allow
specif
molecul
pass
csf
sampl
analysi
three
patient
base
silver
nanoshellsassist
ldi
ms
mannitol
concentr
show
minor
increas
min
intraven
inject
therapeut
treatment
fig
supplementari
tabl
p
contrast
mannitol
concentr
drug
deliveri
significantli
higher
untreat
one
increas
serum
sampl
patient
fig
supplementari
fig
supplementari
tabl
p
bloodbraincsfbarri
fundament
import
maintain
normal
physiolog
activ
live
system
wherea
molecular
permeabl
barrier
guid
use
drug
clinic
practic
result
demonstr
applic
silver
nanoshel
matrix
ldi
ms
investig
function
bloodbraincsfbarri
divid
blood
braincsf
system
well
permeabl
enabl
pass
mannitol
consid
advantag
silver
nanoshellsassist
ldi
ms
esi
ms
requir
sampl
pretreat
ldi
ms
use
matric
supplementari
fig
anticip
approach
engag
advanc
pharmacokinet
studi
variou
small
metabolit
drug
largescal
clinic
use
summari
introduc
silver
nanoshel
sio
ag
matric
direct
ldi
ms
detect
small
metabolit
biofluid
develop
platform
technolog
metabol
analysisbas
diseas
detect
therapeut
evalu
synthes
seri
silver
nanoshel
control
structur
multicycl
silver
mirror
reaction
select
design
silver
nanoshel
optim
analyt
perform
reveal
mechan
effici
ldi
process
associ
structur
paramet
materi
demonstr
applic
complex
biofluid
real
case
furthermor
coupl
isotop
quantif
select
metabolit
eg
glucos
mannitol
identifi
patient
postop
brain
infect
csf
analysi
also
monitor
drug
concentr
csf
serum
investig
bloodbraincsfbarri
pharmacokinet
studi
work
contribut
design
materi
highperform
metabol
analysi
toward
precis
medicin
initi
develop
divers
advanc
diagnost
tool
involv
variou
metabol
biomark
chemic
reagent
ammonium
hydroxid
tetraethyl
orthosil
teo
ethanol
absolut
silver
nitrat
sodium
chlorid
potassium
chlorid
trifluoroacet
acid
tfa
purchas
sinopharm
chemic
reagent
beij
co
ltd
beij
china
acetonitril
acn
acid
chca
dithiothreitol
dtt
cetyltrimethylammonium
chlorid
ctac
albumin
bovin
serum
bsa
polyvinylpyrrolidon
pvp
mw
dglucos
lmethionin
dmannitol
llactic
acid
larginin
ltryptophan
uric
acid
dlphenylalanin
purchas
sigma
usa
tri
base
phosphatebuff
salin
pb
ph
cellcultur
grade
purchas
yeason
biotechnolog
co
ltd
shanghai
china
isotop
intern
standard
glucos
label
six
c
one
c
mannitol
label
one
c
purchas
cambridg
isotop
laboratori
cil
usa
thiolaptam
obtain
sangon
biotech
co
ltd
shanghai
china
aqueou
solut
prepar
use
deioniz
water
cm
milliq
millipor
gmbh
throughout
experi
synthesi
materi
sio
ag
coreshel
particl
prepar
control
surfac
coat
silver
silica
nanoparticl
smooth
uniform
silica
nanoparticl
synthes
hard
templat
use
method
perform
surfac
coat
silver
mirror
reaction
use
overal
g
prepar
silica
nanoparticl
dispers
ml
ethanol
solut
typic
reaction
cycl
freshli
prepar
ag
nh
ion
solut
ml
quickli
ad
particl
dispers
sonic
room
temperatur
min
particl
mix
ml
pvp
ethanol
solut
mm
experi
pvp
employ
stabil
reduct
mixtur
stir
h
format
silver
nanoshel
sio
ag
structur
silver
nanoshel
adjust
conduct
reaction
toward
optim
condit
h
increas
temperatur
time
may
caus
unwant
precipit
round
obtain
sio
result
product
wash
ml
ethanol
deioniz
water
centrifug
min
three
time
final
sio
ag
particl
dri
store
powder
uvvi
spectra
particl
check
qualifi
particl
would
show
absorpt
peak
nm
without
red
shift
suggest
overload
silver
gold
nanoparticl
synthes
use
insolut
seed
approach
seed
solut
firstli
prepar
vigor
mix
ml
aqueou
ctac
solut
ml
haucl
mm
ml
nabh
solut
solut
age
least
h
hot
bath
dilut
ten
time
next
ml
ctac
solut
mix
ml
haucl
mm
ml
ascorb
acid
overal
ml
dilut
seed
solut
ad
mix
solut
sonic
kept
dark
day
obtain
final
gold
nanoparticl
centrifug
wash
water
surfac
function
modifi
silver
nanoshel
aptam
use
postgraft
method
briefli
pb
buffer
ad
od
shmodifi
kanamycin
aptam
ch
final
concentr
dtt
solut
mix
aptam
solut
incub
h
sio
mg
ml
ad
system
gentli
shaken
room
temperatur
h
addit
nacl
h
incub
mixtur
centrifug
min
redispers
pb
materi
character
method
tem
imag
hrtem
imag
element
map
imag
collect
use
jeol
instrument
normal
ethanol
suspens
materi
deposit
onto
copper
grid
observ
sampl
prepar
element
map
mg
ml
water
dispers
sio
mix
glucos
vv
min
supernat
discard
centrifug
min
precipit
wash
redispers
water
put
onto
microgrid
analysi
inter
planar
space
measur
digit
micrograph
version
softwar
gatan
sem
imag
edx
spectra
record
hitachi
drop
materi
suspens
aluminum
foil
room
temperatur
optic
absorpt
spectra
materi
obtain
auci
spectrophotomet
fourier
transform
infrar
spectroscopi
ftir
perform
nicolet
mx
thermo
scientif
usa
nitrogen
adsorpt
isotherm
obtain
micromerit
asap
sampl
degass
vacuum
test
zeta
potenti
dynam
light
scatter
size
measur
perform
instrument
water
malvern
worcestershir
uk
mass
spectrometri
analysi
ldi
ms
detect
metabolit
standard
small
molecul
glucos
mannitol
methionin
tryptophan
uric
acid
lactic
acid
arginin
phenylalanin
dissolv
deioniz
water
stepwis
dilut
concentr
rang
ng
standard
molecul
mix
salt
nacl
kcl
protein
bsa
mg
ml
explor
detect
effici
complex
sampl
typic
ldi
ms
experi
sio
ag
particl
gold
nanoparticl
dispers
water
concentr
mg
ml
matrix
use
chca
dissolv
tfa
buffer
wateracn
vv
concentr
mg
ml
nl
matrix
slurri
deposit
nl
analyt
solut
stainless
steel
target
plate
dri
ldi
ms
analysi
mass
spectra
collect
reflect
mode
employ
delay
extract
proteom
analyz
appli
biosystem
framingham
usa
nd
yag
laser
khz
nm
repetit
rate
acceler
voltag
set
hz
kv
respect
delay
time
experi
optim
ns
number
laser
shot
per
analysi
ldi
ms
experi
ms
signal
signaltonois
ratio
use
identif
molecul
mass
calibr
conduct
background
substrat
mass
peak
ag
n
n
spectrum
accur
mass
measur
msm
select
molecular
peak
glucos
mannitol
biosampl
standard
perform
compar
identif
purpos
addit
accur
mass
measur
mass
accuraci
within
ppm
compar
previou
report
smooth
procedur
appli
spectra
directli
use
analysi
enrich
detect
kanamycin
aptam
modifi
silver
nanoshel
slurri
centrifug
precipit
redispers
trishcl
buffer
ph
mm
overal
ml
kanamycin
differ
concentr
nm
mix
dispers
incub
h
mixtur
centrifug
discard
supernat
redispers
tfa
buffer
wateracn
vv
ldi
ms
analysi
establish
isotop
quantif
isotop
select
metabolit
introduc
intern
standard
quantif
use
standard
solut
small
molecul
differ
concentr
employ
plot
calibr
curv
isotop
dissolv
water
concentr
ng
ng
glucos
mannitol
respect
typic
isotop
solut
mix
analyt
solut
volum
ratio
drop
nl
mixtur
solut
plate
nl
matrix
solut
deposit
onto
dri
ldi
ms
analysi
influenc
natur
occur
c
c
c
elimin
subtract
correspond
signal
intens
quantif
process
use
isotop
one
c
quantif
purpos
rel
intens
ratio
analytesisotop
five
independ
experi
record
data
shown
mean
sd
n
biochem
colorimetr
method
glucos
level
nativ
cerebrospin
fluid
sampl
detect
use
tradit
biochem
approach
dehydrogenas
assay
abbott
diagnost
maidenhead
uk
glucos
concentr
obtain
enzymat
catalysi
glucos
accord
colorimetr
method
statist
analysi
statist
analysi
work
includ
materi
character
bioanalyt
result
perform
base
spss
softwar
version
spss
inc
chicago
calcul
pvalu
statist
demonstr
includ
independ
sampl
ttest
pair
ttest
onesid
ttest
wilcoxon
signedrank
test
diagnosi
brain
infect
csf
sampl
donat
patient
children
hospit
shanghai
csf
sampl
brain
infect
monitor
collect
four
consecut
day
oper
diagnost
applic
csf
sampl
obtain
infect
patient
sampl
obtain
uninfect
control
investig
protocol
studi
approv
institut
ethic
committe
children
hospit
shanghai
school
biomed
engin
sjtu
inform
consent
patient
obtain
sinc
project
start
sampl
harvest
tube
continu
drainag
without
tediou
lumbar
punctur
accord
standard
clinic
procedur
store
use
csf
sampl
directli
detect
ldi
ms
use
silver
nanoshel
matrix
follow
previou
protocol
standard
analysi
five
independ
experi
perform
data
shown
mean
sd
n
diagnost
use
pharmacokinet
studi
pharmacokinet
studi
blood
csf
sampl
donat
three
patient
cerebr
edema
min
rapid
intraven
inject
mannitol
infus
solut
shandong
qidu
pharmaceut
co
ltd
china
surgic
oper
investig
protocol
studi
approv
institut
ethic
committe
children
hospit
shanghai
school
biomed
engin
sjtu
inform
consent
patient
obtain
sinc
project
start
harvest
serum
sampl
complet
vein
blood
draw
base
establish
method
wherea
sampl
csf
brain
infect
diagnosi
experi
serum
csf
sampl
directli
detect
ldi
ms
use
silver
nanoshel
matrix
follow
previou
protocol
standard
analysi
five
independ
experi
perform
data
shown
mean
sd
n
pharmacokinet
studi
data
avail
data
support
find
studi
avail
correspond
author
upon
reason
request
receiv
octob
accept
june
